-
1
-
-
85064852610
-
Infectious disease threats in the twenty-first century: Strengthening the global response
-
Bloom, D.E.; Cadarette, D. Infectious disease threats in the twenty-first century: Strengthening the global response. Front. Immunol. 2019, 10, 549. [CrossRef] [PubMed]
-
(2019)
Front. Immunol.
, vol.10
, pp. 549
-
-
Bloom, D.E.1
Cadarette, D.2
-
2
-
-
85079764301
-
-
Available online:, accessed on 2 February 2020)
-
World Health Organization. Novel Coronavirus—China. Available online: http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/(accessed on 2 February 2020).
-
Novel Coronavirus—China
-
-
-
3
-
-
85078262578
-
Clinical features of patients infected with 2019 novel coronavirus in wuhan, China
-
Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet 2020, 395, 469–470. [CrossRef]
-
(2020)
Lancet
, vol.395
, pp. 469-470
-
-
Huang, C.1
Wang, Y.2
Li, X.3
Ren, L.4
Zhao, J.5
Hu, Y.6
Zhang, L.7
Fan, G.8
Xu, J.9
Gu, X.10
-
4
-
-
85079891404
-
-
World Health Organization. Statement on the second meeting of the International Health Regulations Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV). 2015. Available online: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (accessed on 10 February 2020).
-
(2015)
-
-
-
5
-
-
85078741591
-
Genomic characterization and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding
-
Lu, R.; Zhao, X.; Li, J.; Niu, P.; Yang, B.; Wu, H.; Wang, W.; Song, H.; Huang, B.; Zhu, N.; et al. Genomic characterization and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020, 395, 565–574. [CrossRef]
-
(2020)
Lancet
, vol.395
, pp. 565-574
-
-
Lu, R.1
Zhao, X.2
Li, J.3
Niu, P.4
Yang, B.5
Wu, H.6
Wang, W.7
Song, H.8
Huang, B.9
Zhu, N.10
-
6
-
-
81155151446
-
Coronavirus pathogenesis
-
Weiss, S.R.; Leibowitz, J.L. Coronavirus pathogenesis. Adv. Virus. Res. 2011, 81, 85–164. [CrossRef] [PubMed]
-
(2011)
Adv. Virus. Res.
, vol.81
, pp. 85-164
-
-
Weiss, S.R.1
Leibowitz, J.L.2
-
7
-
-
84992052428
-
Structure, Function, and evolution of coronavirus spike proteins
-
Li, F. Structure, Function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 2016, 3, 237–261. [CrossRef]
-
(2016)
Annu. Rev. Virol.
, vol.3
, pp. 237-261
-
-
Li, F.1
-
8
-
-
85058193722
-
Origin and evolution of pathogenic coronaviruses
-
Cui, J.; Li, F.; Shi, Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019, 17, 181–192. [CrossRef]
-
(2019)
Nat. Rev. Microbiol.
, vol.17
, pp. 181-192
-
-
Cui, J.1
Li, F.2
Shi, Z.L.3
-
9
-
-
27744531541
-
Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E
-
Vijgen, L.; Keyaerts, E.; Moës, E.; Maes, P.; Duson, G.; Van Ranst, M. Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E. J. Clin. Microbiol. 2005, 43, 5452–5456. [CrossRef]
-
(2005)
J. Clin. Microbiol.
, vol.43
, pp. 5452-5456
-
-
Vijgen, L.1
Keyaerts, E.2
Moës, E.3
Maes, P.4
Duson, G.5
van Ranst, M.6
-
10
-
-
85080034896
-
A novel Coronavirus from patients with pneumonia in China, 2019
-
Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; et al. A novel Coronavirus from patients with pneumonia in China, 2019. New. Engl. J. Med. 2020, 382, 727–733. [CrossRef]
-
(2020)
New. Engl. J. Med.
, vol.382
, pp. 727-733
-
-
Zhu, N.1
Zhang, D.2
Wang, W.3
Li, X.4
Yang, B.5
Song, J.6
Zhao, X.7
Huang, B.8
Shi, W.9
Lu, R.10
-
11
-
-
85079157440
-
-
Available online:, (accessed on 10 February 2020)
-
World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report. Available online: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200208-sitrep-19-ncov.pdf (accessed on 10 February 2020).
-
Novel Coronavirus (2019-Ncov) Situation Report.
-
-
-
12
-
-
85078241697
-
A familial cluster of Pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster
-
Chan, J.F.; Yuan, S.; Kok, K.H.; To, K.W.; Chu, H.; Yang, J.; Xing, F.; Liu, J.; Yip, C.Y.; Poon, R.S.; et al. A familial cluster of Pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020, 395, 514–523. [CrossRef]
-
(2020)
Lancet
, vol.395
, pp. 514-523
-
-
Chan, J.F.1
Yuan, S.2
Kok, K.H.3
To, K.W.4
Chu, H.5
Yang, J.6
Xing, F.7
Liu, J.8
Yip, C.Y.9
Poon, R.S.10
-
13
-
-
0013074820
-
A major outbreak of severe acute respiratory syndrome in Hong Kong. New. Engl
-
Lee, N.; Hui, D.; Wu, A.; Chan, P.; Cameron, P.; Joynt, G.M.; Ahuja, A.; Yung, M.Y.; Leung, C.B.; To, K.F. et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. New. Engl. J. Med. 2003, 348, 1986–1994. [CrossRef]
-
(2003)
J. Med
, vol.348
, pp. 1986-1994
-
-
Lee, N.1
Hui, D.2
Wu, A.3
Chan, P.4
Cameron, P.5
Joynt, G.M.6
Ahuja, A.7
Yung, M.Y.8
Leung, C.B.9
To, K.F.10
-
14
-
-
85078761741
-
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study
-
Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507–513. [CrossRef]
-
(2020)
Lancet
, vol.395
, pp. 507-513
-
-
Chen, N.1
Zhou, M.2
Dong, X.3
Qu, J.4
Gong, F.5
Han, Y.6
Qiu, Y.7
Wang, J.8
Liu, Y.9
Wei, Y.10
-
15
-
-
85002661543
-
Plant expression platform for the production of recombinant pharmaceutical proteins
-
Shanmugaraj, B.M.; Ramalingam, S. Plant expression platform for the production of recombinant pharmaceutical proteins. Austin J. Biotechnol. Bioeng. 2014, 1, 4.
-
(2014)
Austin J. Biotechnol. Bioeng.
, vol.1
, pp. 4
-
-
Shanmugaraj, B.M.1
Ramalingam, S.2
-
16
-
-
79953234180
-
Plant-made pharmaceuticals: Leading products and production platforms
-
Paul, M.; Ma, J.K. Plant-made pharmaceuticals: Leading products and production platforms. Biotechnol. Appl. Biochem. 2011, 58, 58–67. [CrossRef]
-
(2011)
Biotechnol. Appl. Biochem.
, vol.58
, pp. 58-67
-
-
Paul, M.1
Ma, J.K.2
-
17
-
-
85075992522
-
Plant-produced anti-Enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection
-
Rattanapisit, K.; Chao, Z.; Siriwattananon, K.; Huang, Z.; Phoolcharoen, W. Plant-produced anti-Enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection. Plants 2019, 8, 560. [CrossRef]
-
(2019)
Plants
, vol.8
, pp. 560
-
-
Rattanapisit, K.1
Chao, Z.2
Siriwattananon, K.3
Huang, Z.4
Phoolcharoen, W.5
-
18
-
-
85067556772
-
Cold chain and virus-free oral polio booster vaccine made in lettuce chloroplasts confers protection against all three poliovirus serotypes
-
Daniell, H.; Rai, V.; Xiao, Y. Cold chain and virus-free oral polio booster vaccine made in lettuce chloroplasts confers protection against all three poliovirus serotypes. Plant Biotechnol. J. 2019, 17, 1357–1368. [CrossRef]
-
(2019)
Plant Biotechnol. J.
, vol.17
, pp. 1357-1368
-
-
Daniell, H.1
Rai, V.2
Xiao, Y.3
-
19
-
-
85075231964
-
Production and immunogenicity of soluble plant-produced HIV-1 subtype C envelope gp140 immunogens
-
[CrossRef]
-
Margolin, E.; Chapman, R.; Meyers, A.E.; van Diepen, M.T.; Ximba, P.; Hermanus, T.; Crowther, C.; Weber, B.; Morris, L.; Williamson, A.L.; et al. Production and immunogenicity of soluble plant-produced HIV-1 subtype C envelope gp140 immunogens. Front. Plant Sci. 2019, 10, 1378. [CrossRef]
-
(2019)
Front. Plant Sci.
, vol.10
, pp. 1378
-
-
Margolin, E.1
Chapman, R.2
Meyers, A.E.3
van Diepen, M.T.4
Ximba, P.5
Hermanus, T.6
Crowther, C.7
Weber, B.8
Morris, L.9
Williamson, A.L.10
-
20
-
-
84899630021
-
Taliglucerase alfa: An enzyme replacement therapy using plant cell expression technology
-
Grabowski, G.A.; Golembo, M.; Shaaltiel, Y. Taliglucerase alfa: An enzyme replacement therapy using plant cell expression technology. Mol. Genet. Metab. 2014, 112, 1–8. [CrossRef]
-
(2014)
Mol. Genet. Metab.
, vol.112
, pp. 1-8
-
-
Grabowski, G.A.1
Golembo, M.2
Shaaltiel, Y.3
-
21
-
-
85074994662
-
Molecular Pharming for low and middle income countries
-
[CrossRef]
-
Murad, S.; Fuller, S.; Menary, J.; Moore, C.; Pinneh, E.; Szeto, T.; Hitzeroth, I.; Freire, M.; Taychakhoonavudh, S.; Phoolcharoen, W.; et al. Molecular Pharming for low and middle income countries. Curr. Opin. Biotechnol. 2019, 61, 53–59. [CrossRef]
-
(2019)
Curr. Opin. Biotechnol.
, vol.61
, pp. 53-59
-
-
Murad, S.1
Fuller, S.2
Menary, J.3
Moore, C.4
Pinneh, E.5
Szeto, T.6
Hitzeroth, I.7
Freire, M.8
Taychakhoonavudh, S.9
Phoolcharoen, W.10
-
22
-
-
84936865223
-
Plant-based vaccines against viruses
-
Rybicki, E.P. Plant-based vaccines against viruses. Virol. J. 2014, 11, 205. [CrossRef]
-
(2014)
Virol. J.
, vol.11
-
-
Rybicki, E.P.1
-
23
-
-
84942199558
-
Plant-made oral vaccines against human infectious diseases-Are we there yet?
-
Chan, H.T.; Daniell, H. Plant-made oral vaccines against human infectious diseases-Are we there yet? Plant Biotechnol. J. 2015, 13, 1056–1070. [CrossRef]
-
(2015)
Plant Biotechnol. J.
, vol.13
, pp. 1056-1070
-
-
Chan, H.T.1
Daniell, H.2
-
24
-
-
84942133215
-
Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents
-
Streatfield, S.J.; Kushnir, N.; Yusibov, V. Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents. Plant Biotechnol. J. 2015, 13, 1136–1159. [CrossRef] [PubMed]
-
(2015)
Plant Biotechnol. J.
, vol.13
, pp. 1136-1159
-
-
Streatfield, S.J.1
Kushnir, N.2
Yusibov, V.3
-
25
-
-
85017225316
-
A perspective on the development of plant-made vaccines in the fight against Ebola virus
-
Rosales-Mendoza, S.; Nieto-Gómez, R.; Angulo, C. A perspective on the development of plant-made vaccines in the fight against Ebola virus. Front. Immunol. 2017, 8, 252. [CrossRef] [PubMed]
-
(2017)
Front. Immunol.
, vol.8
, pp. 252
-
-
Rosales-Mendoza, S.1
Nieto-Gómez, R.2
Angulo, C.3
-
26
-
-
85013500966
-
Expression and functional evaluation of biopharmaceuticals made in plant chloroplasts
-
Zhang, B.; Shanmugaraj, B.; Daniell, H. Expression and functional evaluation of biopharmaceuticals made in plant chloroplasts. Curr. Opin. Chem. Biol. 2017, 38, 17–23. [CrossRef] [PubMed]
-
(2017)
Curr. Opin. Chem. Biol.
, vol.38
, pp. 17-23
-
-
Zhang, B.1
Shanmugaraj, B.2
Daniell, H.3
-
27
-
-
85077303669
-
Development of systems for the production of plant-derived biopharmaceuticals
-
Moon, K.B.; Park, J.S.; Park, Y.I.; Song, I.J.; Lee, H.J.; Cho, H.S.; Jeon, J.H.; Kim, H.S. Development of systems for the production of plant-derived biopharmaceuticals. Plants 2020, 9, 30. [CrossRef] [PubMed]
-
(2020)
Plants
, vol.9
, pp. 30
-
-
Moon, K.B.1
Park, J.S.2
Park, Y.I.3
Song, I.J.4
Lee, H.J.5
Cho, H.S.6
Jeon, J.H.7
Kim, H.S.8
-
28
-
-
78649827714
-
Antibody responses in mice stimulated by various doses of the potato-derived major surface antigen of hepatitis B virus
-
Youm, J.W.; Won, Y.S.; Jeon, J.H.; Moon, K.B.; Kim, H.C.; Shin, K.S.; Joung, H.; Kim, H.S. Antibody responses in mice stimulated by various doses of the potato-derived major surface antigen of hepatitis B virus. Clin. Vaccine Immunol. 2010, 17, 2029–2032. [CrossRef]
-
(2010)
Clin. Vaccine Immunol.
, vol.17
, pp. 2029-2032
-
-
Youm, J.W.1
Won, Y.S.2
Jeon, J.H.3
Moon, K.B.4
Kim, H.C.5
Shin, K.S.6
Joung, H.7
Kim, H.S.8
-
29
-
-
84908323659
-
Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B
-
Czyz, M.; Dembczyński, R.; Marecik, R.; Wojas-Turek, J.; Milczarek, M.; Pajtasz-Piasecka, E.; Wietrzyk, J.; Pniewski, T. Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B. Biomed. Res. Int. 2014, 2014, 485689. [CrossRef]
-
(2014)
Biomed. Res. Int.
, vol.2014
-
-
Czyz, M.1
Dembczyński, R.2
Marecik, R.3
Wojas-Turek, J.4
Milczarek, M.5
Pajtasz-Piasecka, E.6
Wietrzyk, J.7
Pniewski, T.8
-
30
-
-
84893981474
-
Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen
-
Hayden, C.A.; Smith, E.M.; Turner, D.D.; Keener, T.K.; Wong, J.C.; Walker, J.H.; Tizard, I.R.; Jimenez-Flores, R.; Howard, J.A. Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen. Vaccine 2014, 32, 1240–1246. [CrossRef]
-
(2014)
Vaccine
, vol.32
, pp. 1240-1246
-
-
Hayden, C.A.1
Smith, E.M.2
Turner, D.D.3
Keener, T.K.4
Wong, J.C.5
Walker, J.H.6
Tizard, I.R.7
Jimenez-Flores, R.8
Howard, J.A.9
-
31
-
-
79955652900
-
Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice
-
Gonzalez-Rabade, N.; McGowan, E.G.; Zhou, F.; McCabe, M.S.; Bock, R.; Dix, P.J.; Gray, J.C.; Ma, J.K. Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice. Plant Biotechnol. J. 2011, 9, 629–638. [CrossRef]
-
(2011)
Plant Biotechnol. J.
, vol.9
, pp. 629-638
-
-
Gonzalez-Rabade, N.1
McGowan, E.G.2
Zhou, F.3
McCabe, M.S.4
Bock, R.5
Dix, P.J.6
Gray, J.C.7
Ma, J.K.8
-
32
-
-
84857050700
-
A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice
-
Rubio-Infante, N.; Govea-Alonso, D.O.; Alpuche-Solís, Á.G.; García-Hernández, A.L.; Soria-Guerra, R.E.; Paz-Maldonado, L.M.; Ilhuicatzi-Alvarado, D.; Varona-Santos, J.T.; Verdín-Terán, L.; Korban, S.S.; et al. A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice. Plant Mol. Biol. 2012, 78, 337–349. [CrossRef]
-
(2012)
Plant Mol. Biol.
, vol.78
, pp. 337-349
-
-
Rubio-Infante, N.1
Govea-Alonso, D.O.2
Alpuche-Solís, Á.G.3
García-Hernández, A.L.4
Soria-Guerra, R.E.5
Paz-Maldonado, L.M.6
Ilhuicatzi-Alvarado, D.7
Varona-Santos, J.T.8
Verdín-Terán, L.9
Korban, S.S.10
-
33
-
-
84930872533
-
A plant-derived Multi-HIV antigen induces broad immune responses in orally immunized mice
-
Rubio-Infante, N.; Govea-Alonso, D.O.; Romero-Maldonado, A.; García-Hernández, A.L.; Ilhuicatzi-Alvarado, D.; Salazar-González, J.A.; Korban, S.S.; Rosales-Mendoza, S.; Moreno-Fierros, L. A plant-derived Multi-HIV antigen induces broad immune responses in orally immunized mice. Mol. Biotechnol. 2015, 57, 662–674. [CrossRef]
-
(2015)
Mol. Biotechnol.
, vol.57
, pp. 662-674
-
-
Rubio-Infante, N.1
Govea-Alonso, D.O.2
Romero-Maldonado, A.3
García-Hernández, A.L.4
Ilhuicatzi-Alvarado, D.5
Salazar-González, J.A.6
Korban, S.S.7
Rosales-Mendoza, S.8
Moreno-Fierros, L.9
-
34
-
-
84884671007
-
Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein
-
Govea-Alonso, D.O.; Rubio-Infante, N.; García-Hernández, A.L.; Varona-Santos, J.T.; Korban, S.S.; Moreno-Fierros, L.; Rosales-Mendoza, S. Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein. Planta 2013, 238, 785–792. [CrossRef] [PubMed]
-
(2013)
Planta
, vol.238
, pp. 785-792
-
-
Govea-Alonso, D.O.1
Rubio-Infante, N.2
García-Hernández, A.L.3
Varona-Santos, J.T.4
Korban, S.S.5
Moreno-Fierros, L.6
Rosales-Mendoza, S.7
-
35
-
-
84897502968
-
Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses
-
Lindh, I.; Bráve, A.; Hallengärd, D.; Hadad, R.; Kalbina, I.; Strid, A.; Andersson, S. Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses. Vaccine 2014, 32, 2288–2293. [CrossRef] [PubMed]
-
(2014)
Vaccine
, vol.32
, pp. 2288-2293
-
-
Lindh, I.1
Bráve, A.2
Hallengärd, D.3
Hadad, R.4
Kalbina, I.5
Strid, A.6
Andersson, S.7
-
36
-
-
84874708451
-
Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice
-
Liu, H.; Li, X.; Lei, T.; Li, W.; Si, L.; Zheng, J. Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice. Hum. Vaccines Immunother. 2013, 9, 83–89. [CrossRef]
-
(2013)
Hum. Vaccines Immunother.
, vol.9
, pp. 83-89
-
-
Liu, H.1
Li, X.2
Lei, T.3
Li, W.4
Si, L.5
Zheng, J.6
-
37
-
-
84895073283
-
Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model
-
Monroy-García, A.; Gómez-Lim, M.A.; Weiss-Steider, B.; Hernández-Montes, J.; Huerta-Yepez, S.; Rangel-Santiago, J.F.; Santiago-Osorio, E.; de Mora García, M.L. Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model. Arch. Virol. 2014, 159, 291–305. [CrossRef] [PubMed]
-
(2014)
Arch. Virol.
, vol.159
, pp. 291-305
-
-
Monroy-García, A.1
Gómez-Lim, M.A.2
Weiss-Steider, B.3
Hernández-Montes, J.4
Huerta-Yepez, S.5
Rangel-Santiago, J.F.6
Santiago-Osorio, E.7
de Mora García, M.L.8
-
38
-
-
84939933128
-
Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice
-
Nahampun, H.N.; Bosworth, B.; Cunnick, J.; Mogler, M.; Wang, K. Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice. Plant Cell Rep. 2015, 34, 969–980. [CrossRef]
-
(2015)
Plant Cell Rep
, vol.34
, pp. 969-980
-
-
Nahampun, H.N.1
Bosworth, B.2
Cunnick, J.3
Mogler, M.4
Wang, K.5
-
39
-
-
84864306068
-
Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein
-
Loza-Rubio, E.; Rojas-Anaya, E.; López, J.; Olivera-Flores, M.T.; Gómez-Lim, M.; Tapia-Pérez, G. Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein. Vaccine 2012, 30, 5551–5556. [CrossRef]
-
(2012)
Vaccine
, vol.30
, pp. 5551-5556
-
-
Loza-Rubio, E.1
Rojas-Anaya, E.2
López, J.3
Olivera-Flores, M.T.4
Gómez-Lim, M.5
Tapia-Pérez, G.6
-
40
-
-
84925863957
-
Expression of rabies glycoprotein and ricin toxin B chain (RGP-RTB) fusion protein in tomato hairy roots: A step towards oral vaccination for rabies
-
Singh, A.; Srivastava, S.; Chouksey, A.; Panwar, B.S.; Verma, P.C.; Roy, S.; Singh, P.K.; Saxena, G.; Tuli, R. Expression of rabies glycoprotein and ricin toxin B chain (RGP-RTB) fusion protein in tomato hairy roots: A step towards oral vaccination for rabies. Mol. Biotechnol. 2015, 57, 359–370. [CrossRef]
-
(2015)
Mol. Biotechnol.
, vol.57
, pp. 359-370
-
-
Singh, A.1
Srivastava, S.2
Chouksey, A.3
Panwar, B.S.4
Verma, P.C.5
Roy, S.6
Singh, P.K.7
Saxena, G.8
Tuli, R.9
-
41
-
-
85027954245
-
Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes
-
Chan, H.T.; Xiao, Y.; Weldon, W.C.; Oberste, S.M.; Chumakov, K.; Daniell, H. Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes. Plant Biotechnol. J. 2016, 14, 2190–2200. [CrossRef]
-
(2016)
Plant Biotechnol. J.
, vol.14
, pp. 2190-2200
-
-
Chan, H.T.1
Xiao, Y.2
Weldon, W.C.3
Oberste, S.M.4
Chumakov, K.5
Daniell, H.6
-
42
-
-
85027512605
-
Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine
-
Marsian, J.; Fox, H.; Bahar, M.W.; Kotecha, A.; Fry, E.E.; Stuart, D.I.; Macadam, A.J.; Rowlands, D.J.; Lomonossoff, G.P. Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine. Nat. Commun. 2017, 8, 245. [CrossRef]
-
(2017)
Nat. Commun.
, vol.8
-
-
Marsian, J.1
Fox, H.2
Bahar, M.W.3
Kotecha, A.4
Fry, E.E.5
Stuart, D.I.6
Macadam, A.J.7
Rowlands, D.J.8
Lomonossoff, G.P.9
-
43
-
-
79961171492
-
Expression of an immunogenic Ebola immune complex in Nicotiana Benthamiana
-
Phoolcharoen, W.; Bhoo, S.H.; Lai, H.; Ma, J.; Arntzen, C.J.; Chen, Q.; Mason, H.S. Expression of an immunogenic Ebola immune complex in Nicotiana Benthamiana. Plant Biotechnol. J. 2011, 9, 807–816. [CrossRef]
-
(2011)
Plant Biotechnol. J.
, vol.9
, pp. 807-816
-
-
Phoolcharoen, W.1
Bhoo, S.H.2
Lai, H.3
Ma, J.4
Arntzen, C.J.5
Chen, Q.6
Mason, H.S.7
-
44
-
-
85007256378
-
Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity
-
Dent, M.; Hurtado, J.; Paul, A.M.; Sun, H.; Lai, H.; Yang, M.; Esqueda, A.; Bai, F.; Steinkellner, H.; Chen, Q. Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity. J. Gen. Virol. 2016, 97, 3280–3290. [CrossRef]
-
(2016)
J. Gen. Virol.
, vol.97
, pp. 3280-3290
-
-
Dent, M.1
Hurtado, J.2
Paul, A.M.3
Sun, H.4
Lai, H.5
Yang, M.6
Esqueda, A.7
Bai, F.8
Steinkellner, H.9
Chen, Q.10
-
45
-
-
84896545772
-
Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco
-
Teh, A.Y.-H.; Maresch, D.; Klein, K.; Ma, J.K.-C. Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco. Plant Biotechnol. J. 2014, 12, 300–311. [CrossRef] [PubMed]
-
(2014)
Plant Biotechnol. J.
, vol.12
, pp. 300-311
-
-
Teh, A.Y.-H.1
Maresch, D.2
Klein, K.3
Ma, J.K.-C.4
-
46
-
-
84942199585
-
Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants
-
Ma, J.K.C.; Drossard, J.; Lewis, D.; Altmann, F.; Boyle, J.; Christou, P.; Cole, T.; Dale, P.; van Dolleweerd, C.J.; Isitt, V.; et al. Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. Plant Biotechnol. J. 2015, 13, 1106–1120. [CrossRef] [PubMed]
-
(2015)
Plant Biotechnol. J.
, vol.13
, pp. 1106-1120
-
-
Ma, J.K.C.1
Drossard, J.2
Lewis, D.3
Altmann, F.4
Boyle, J.5
Christou, P.6
Cole, T.7
Dale, P.8
van Dolleweerd, C.J.9
Isitt, V.10
-
47
-
-
84903940385
-
Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody
-
Van Dolleweerd, C.J.; Teh, A.Y.; Banyard, A.C.; Both, L.; Lotter-Stark, H.C.; Tsekoa, T.; Phahladira, B.; Shumba, W.; Chakauya, E.; Sabeta, C.T.; et al. Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody. J. Infect. Dis. 2014, 210, 200–208. [CrossRef] [PubMed]
-
(2014)
J. Infect. Dis
, vol.210
, pp. 200-208
-
-
van Dolleweerd, C.J.1
Teh, A.Y.2
Banyard, A.C.3
Both, L.4
Lotter-Stark, H.C.5
Tsekoa, T.6
Phahladira, B.7
Shumba, W.8
Chakauya, E.9
Sabeta, C.T.10
-
48
-
-
84877101550
-
Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans
-
Both, L.; van Dolleweerd, C.; Wright, E.; Banyard, A.C.; Bulmer-Thomas, B.; Selden, D.; Altmann, F.; Fooks, A.R.; Ma, J.K. Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans. FASEB J. 2013, 27, 2055–2065. [CrossRef] [PubMed]
-
(2013)
FASEB J
, vol.27
, pp. 2055-2065
-
-
Both, L.1
van Dolleweerd, C.2
Wright, E.3
Banyard, A.C.4
Bulmer-Thomas, B.5
Selden, D.6
Altmann, F.7
Fooks, A.R.8
Ma, J.K.9
-
49
-
-
85018586734
-
Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device
-
Phoolcharoen, W.; Prehaud, C.; van Dolleweerd, C.J.; Both, L.; da Costa, A.; Lafon, M.; Ma, J.K. Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device. Plant Biotechnol. J. 2017, 15, 1331–1339. [CrossRef]
-
(2017)
Plant Biotechnol. J.
, vol.15
, pp. 1331-1339
-
-
Phoolcharoen, W.1
Prehaud, C.2
van Dolleweerd, C.J.3
Both, L.4
da Costa, A.5
Lafon, M.6
Ma, J.K.7
-
50
-
-
85079865064
-
-
Mapp Biopharmaceutical, Inc, accessed on 8 February 2020
-
Mapp Biopharmaceutical, Inc. Available online: http://mappbio.com (accessed on 8 February 2020).
-
-
-
-
51
-
-
85078761789
-
A Broad and potent H1-specific human monoclonal antibody produced in plants prevents Influenza virus infection and transmission in Guinea Pigs
-
Park, J.G.; Ye, C.; Piepenbrink, M.S.; Nogales, A.; Wang, H.; Shuen, M.; Meyers, A.J.; Martinez-Sobrido, L.; Kobie, J.J. A Broad and potent H1-specific human monoclonal antibody produced in plants prevents Influenza virus infection and transmission in Guinea Pigs. Viruses 2020, 12, 167. [CrossRef]
-
(2020)
Viruses
, vol.12
, pp. 167
-
-
Park, J.G.1
Ye, C.2
Piepenbrink, M.S.3
Nogales, A.4
Wang, H.5
Shuen, M.6
Meyers, A.J.7
Martinez-Sobrido, L.8
Kobie, J.J.9
-
52
-
-
85020273313
-
Rapid transient production of a monoclonal antibody neutralizing the Porcine Epidemic Diarrhea Virus (PEDV) in Nicotiana benthamiana and Lactuca sativa
-
Rattanapisit, K.; Srijangwad, A.; Chuanasa, T.; Sukrong, S.; Tantituvanont, A.; Mason, H.S.; Nilubol, D.; Phoolcharoen, W. Rapid transient production of a monoclonal antibody neutralizing the Porcine Epidemic Diarrhea Virus (PEDV) in Nicotiana benthamiana and Lactuca sativa. Planta Med. 2017, 83, 1412–1419. [CrossRef]
-
(2017)
Planta Med
, vol.83
, pp. 1412-1419
-
-
Rattanapisit, K.1
Srijangwad, A.2
Chuanasa, T.3
Sukrong, S.4
Tantituvanont, A.5
Mason, H.S.6
Nilubol, D.7
Phoolcharoen, W.8
-
53
-
-
85068189460
-
In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants
-
Hurtado, J.; Acharya, D.; Lai, H.; Sun, H.; Kallolimath, S.; Steinkellner, H.; Bai, F.; Chen, Q. In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants. Plant Biotechnol. J. 2020, 18, 266–273. [CrossRef]
-
(2020)
Plant Biotechnol. J.
, vol.18
, pp. 266-273
-
-
Hurtado, J.1
Acharya, D.2
Lai, H.3
Sun, H.4
Kallolimath, S.5
Steinkellner, H.6
Bai, F.7
Chen, Q.8
-
54
-
-
84925932871
-
Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants
-
Lai, H.; He, J.; Hurtado, J.; Stahnke, J.; Fuchs, A.; Mehlhop, E.; Gorlatov, S.; Loos, A.; Diamond, M.S.; Chen, Q. Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants. Plant Biotechnol. J. 2014, 12, 1098–1107. [CrossRef]
-
(2014)
Plant Biotechnol. J.
, vol.12
, pp. 1098-1107
-
-
Lai, H.1
He, J.2
Hurtado, J.3
Stahnke, J.4
Fuchs, A.5
Mehlhop, E.6
Gorlatov, S.7
Loos, A.8
Diamond, M.S.9
Chen, Q.10
-
55
-
-
84942191097
-
Commercialization of new biotechnology: A systematic review of 16 commercial case studies in a novel manufacturing sector
-
Paul, M.J.; Thangaraj, H.; Ma, J.K. Commercialization of new biotechnology: A systematic review of 16 commercial case studies in a novel manufacturing sector. Plant Biotechnol. J. 2015, 13, 1209–1220. [CrossRef] [PubMed]
-
(2015)
Plant Biotechnol. J.
, vol.13
, pp. 1209-1220
-
-
Paul, M.J.1
Thangaraj, H.2
Ma, J.K.3
-
56
-
-
84942198898
-
Plant-made pharmaceuticals: FromEdible Vaccines to Ebola therapeutics
-
Arntzen, C. Plant-made pharmaceuticals: FromEdible Vaccines to Ebola therapeutics. Plant Biotechnol. J. 2015, 13, 1013–1016. [CrossRef] [PubMed]
-
(2015)
Plant Biotechnol. J.
, vol.13
, pp. 1013-1016
-
-
Arntzen, C.1
-
57
-
-
85060061483
-
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
-
Song, Z.; Xu, Y.; Bao, L.; Zhang, L.; Yu, P.; Qu, Y.; Zhu, H.; Zhao, W.; Han, Y.; Qin, C. From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses 2019, 11, 59. [CrossRef] [PubMed]
-
(2019)
Viruses
, vol.11
, pp. 59
-
-
Song, Z.1
Xu, Y.2
Bao, L.3
Zhang, L.4
Yu, P.5
Qu, Y.6
Zhu, H.7
Zhao, W.8
Han, Y.9
Qin, C.10
-
58
-
-
10944238037
-
Severe acute respiratory syndrome
-
Suppl. 12
-
Peiris, J.S.; Guan, Y.; Yuen, K.Y. Severe acute respiratory syndrome. Nat. Med. 2004, 10 (Suppl. 12), S88–S97. [CrossRef]
-
(2004)
Nat. Med.
, vol.10
, pp. S88-S97
-
-
Peiris, J.S.1
Guan, Y.2
Yuen, K.Y.3
-
59
-
-
24944498409
-
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
-
Li, F.; Li, W.; Farzan, M.; Harrison, S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 2005, 309, 1864–1868. [CrossRef]
-
(2005)
Science
, vol.309
, pp. 1864-1868
-
-
Li, F.1
Li, W.2
Farzan, M.3
Harrison, S.C.4
-
60
-
-
0344395657
-
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
-
Li, W.; Moore, M.J.; Vasilieva, N.; Sui, J.; Wong, S.K.; Berne, M.A.; Somasundaran, M.; Sullivan, J.L.; Luzuriaga, K.; Greenough, T.C.; et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426, 450–454. [CrossRef]
-
(2003)
Nature
, vol.426
, pp. 450-454
-
-
Li, W.1
Moore, M.J.2
Vasilieva, N.3
Sui, J.4
Wong, S.K.5
Berne, M.A.6
Somasundaran, M.7
Sullivan, J.L.8
Luzuriaga, K.9
Greenough, T.C.10
-
61
-
-
85079372059
-
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
-
Wan, Y.; Shang, J.; Graham, R.; Baric, R.S.; Li, F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J. Virol. 2020. [CrossRef]
-
(2020)
J. Virol.
-
-
Wan, Y.1
Shang, J.2
Graham, R.3
Baric, R.S.4
Li, F.5
-
62
-
-
84855678360
-
Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: Target, mechanism of action, and therapeutic potential
-
Coughlin, M.M.; Prabhakar, B.S. Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: Target, mechanism of action, and therapeutic potential. Rev. Med. Virol. 2012, 22, 2–17. [CrossRef]
-
(2012)
Rev. Med. Virol.
, vol.22
, pp. 2-17
-
-
Coughlin, M.M.1
Prabhakar, B.S.2
-
63
-
-
85067516383
-
Antibodies and vaccines against Middle East respiratory syndrome coronavirus
-
Xu, J.; Jia, W.; Wang, P.; Zhang, S.; Shi, X.; Wang, X.; Zhang, L. Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Emerg. Microbes. Infect. 2019, 8, 841–856. [CrossRef]
-
(2019)
Emerg. Microbes. Infect.
, vol.8
, pp. 841-856
-
-
Xu, J.1
Jia, W.2
Wang, P.3
Zhang, S.4
Shi, X.5
Wang, X.6
Zhang, L.7
-
64
-
-
85075056854
-
Recent Advances in the vaccine development against Middle East Respiratory Syndrome-Coronavirus
-
Yong, C.Y.; Ong, H.K.; Yeap, S.K.; Ho, K.L.; Tan, W.S. Recent Advances in the vaccine development against Middle East Respiratory Syndrome-Coronavirus. Front. Microbiol. 2019, 10, 1781. [CrossRef]
-
(2019)
Front. Microbiol.
, vol.10
, pp. 1781
-
-
Yong, C.Y.1
Ong, H.K.2
Yeap, S.K.3
Ho, K.L.4
Tan, W.S.5
|